These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy. Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034 [TBL] [Abstract][Full Text] [Related]
4. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease. Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036 [TBL] [Abstract][Full Text] [Related]
5. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD. Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037 [TBL] [Abstract][Full Text] [Related]
6. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications. Targownik LE; Bernstein CN; Lakatos PL; Murthy SK; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Jones JL; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Windsor JW; Panaccione R J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S40-S45. PubMed ID: 34755038 [TBL] [Abstract][Full Text] [Related]
7. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life. Graff LA; Fowler S; Jones JL; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Targownik LE; Windsor JW; Bernstein CN J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S46-S53. PubMed ID: 34755039 [TBL] [Abstract][Full Text] [Related]
8. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care. Jones JL; Benchimol EI; Bernstein CN; Huang JG; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Kaplan GG; Kuenzig ME; Tandon P; Targownik LE; Windsor JW; Bitton A J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S61-S67. PubMed ID: 34755041 [TBL] [Abstract][Full Text] [Related]
9. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations. Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040 [TBL] [Abstract][Full Text] [Related]
10. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary. Windsor JW; Kuenzig ME; Murthy SK; Bitton A; Bernstein CN; Jones JL; Lee K; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Davis T; Weinstein J; Goddard Q; Benchimol EI; Kaplan GG J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S1-S8. PubMed ID: 37674500 [TBL] [Abstract][Full Text] [Related]
11. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. Hilsden RJ; Verhoef MJ; Best A; Pocobelli G BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168 [TBL] [Abstract][Full Text] [Related]
12. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD. Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494 [TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749 [TBL] [Abstract][Full Text] [Related]
14. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis. Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study. Busingye D; Pollack A; Chidwick K PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research. Trindade IA; Ferreira NB Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review. Hormati A; Arezoumand A; Dokhanchi H; Pezeshgi Modarres M; Ahmadpour S Middle East J Dig Dis; 2022 Apr; 14(2):155-166. PubMed ID: 36619145 [No Abstract] [Full Text] [Related]
18. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
19. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada. Benchimol EI; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Siddiq S; Windsor JW; Carroll MW; Coward S; El-Matary W; Griffiths AM; Jones JL; Kuenzig ME; Lee L; Mack DR; Mawani M; Otley AR; Singh H; Targownik LE; Weizman AV; Kaplan GG J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S1-S5. PubMed ID: 31294380 [TBL] [Abstract][Full Text] [Related]
20. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry. Agrawal M; Brenner EJ; Zhang X; Colombel JF; Kappelman MD; Ungaro RC; ; Gearry RB; Kalpan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE J Crohns Colitis; 2021 May; 15(5):860-863. PubMed ID: 33232456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]